clear violat patent said thoma
a. bologna presid gen-prob molecular
biosystem kit target rna key technolog us
product said mr. bologna gen-prob
biotechnolog concern went privat
acquir 1989 chugai pharmaceut co. japan
molecular biosystem presid vincent frank deni
say kit target dna plan defend
alleg said stress
kit sold clinic laboratori compris
less 1 % molecular biosystem annual revenu mr
frank said molecular biosystem biomed concern
notifi gen-prob believ one gen-prob
product patent infring consid
lawsuit mr. frank said
composit trade yesterday new york stock
exchang molecular biosystem stock close $ 29.75
$ 1.25
compani said discuss
issu month gen-prob seek lawsuit recov
molecular biosystem profit sale kit
figur gen-prob yet determin plus trebl damag
